Drug Discovery Services Market Size & Share Forecast - 2032

Drug Discovery Services Market - By Process (Hit-to-Lead Identification, Lead Optimization), Type (Chemistry Services, Biological) Drug Type (Small-molecule), Therapeutic Area (Oncology), End-user (Pharma/Biotech Companies) & Forecast 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Drug discovery services industry 3600synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Process trends

2.1.4&nbsp;&nbsp;&nbsp; Type trends

2.1.5&nbsp;&nbsp;&nbsp; Drug type trends

2.1.6&nbsp;&nbsp;&nbsp; Therapeutic area trends

2.1.7&nbsp;&nbsp;&nbsp; End-user trends

Chapter 3&nbsp;&nbsp;&nbsp;Drug Discovery Services Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing R&amp;D expenditure

3.2.1.2&nbsp;&nbsp;&nbsp;Rising prevalence of chronic disease

3.2.1.3&nbsp;&nbsp;&nbsp;Rising demand for novel therapeutic drugs for treatment

3.2.1.4&nbsp;&nbsp;&nbsp;Rising technological advancements in drug discovery

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulations governing drug discovery

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By process

3.3.2&nbsp;&nbsp;&nbsp; By type

3.3.3&nbsp;&nbsp;&nbsp; By drug type

3.3.4&nbsp;&nbsp;&nbsp; By therapeutic area

3.3.5&nbsp;&nbsp;&nbsp; By end-user

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.7&nbsp;&nbsp;&nbsp; Drug discovery and development process

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

4.6&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By Process (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by process

5.2&nbsp;&nbsp;&nbsp; Target Selection

5.3&nbsp;&nbsp;&nbsp; Target Validation

5.4&nbsp;&nbsp;&nbsp; Hit-to-Lead Identification

5.5&nbsp;&nbsp;&nbsp; Lead Optimization

5.6&nbsp;&nbsp;&nbsp; Candidate Validation

Chapter 6&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By Type (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by type

6.2&nbsp;&nbsp;&nbsp; Chemistry Services

6.3&nbsp;&nbsp;&nbsp; Biological Services

Chapter 7&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By Drug Type (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by drug type

7.2&nbsp;&nbsp;&nbsp; Small-molecule Drugs

7.3&nbsp;&nbsp;&nbsp; Large-molecule Drugs

Chapter 8&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By Therapeutic Area (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by therapeutic area

8.2&nbsp;&nbsp;&nbsp; Diabetes

8.3&nbsp;&nbsp;&nbsp; Neurology

8.4&nbsp;&nbsp;&nbsp; Oncology

8.5&nbsp;&nbsp;&nbsp; Infectious Diseases

8.6&nbsp;&nbsp;&nbsp; Other therapeutic areas

Chapter 9&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By End-user (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by end-user

9.2&nbsp;&nbsp;&nbsp; Pharmaceutical &amp; Biotechnology Companies

9.3&nbsp;&nbsp;&nbsp; Contract Research Organizations

9.4&nbsp;&nbsp;&nbsp; Other End-users

Chapter 10&nbsp;&nbsp;&nbsp;Drug Discovery Services Market Size and Forecast, By Region (USD Million)

10.1&nbsp;&nbsp;&nbsp; Key trends, by region

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; MEA

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc.

11.2&nbsp;&nbsp;&nbsp; QIAGEN

11.3&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

11.4&nbsp;&nbsp;&nbsp; Wuxi AppTec

11.5&nbsp;&nbsp;&nbsp; Merck &amp; Co. Inc.

11.6&nbsp;&nbsp;&nbsp; Eurofins Scientific

11.7&nbsp;&nbsp;&nbsp; GenScript

11.8&nbsp;&nbsp;&nbsp; Laboratory Corporation of American Holdings

11.9&nbsp;&nbsp;&nbsp; EVOTEC

11.10&nbsp;&nbsp;&nbsp; Curia Global, Inc.

11.11&nbsp;&nbsp;&nbsp; Syngene International Limited

11.12&nbsp;&nbsp;&nbsp; TCG Lifesciences Pvt Ltd.

11.13&nbsp;&nbsp;&nbsp; TheraIndx Lifesciences Pvt. Ltd. 
&nbsp;

Drug Discovery Services Market

Inquiry Before Buying